Merck’s Januvia/Metformin Combo To Be Branded Janumet
The sitagliptin fixed-dose combination therapy, formerly known as MK-0431A, has a late March user fee date.
The sitagliptin fixed-dose combination therapy, formerly known as MK-0431A, has a late March user fee date.